Literature DB >> 10218583

Affinity isolation of imidazoline binding proteins from rat brain using 5-amino-efaroxan as a ligand.

L K Monks1, K E Cosgrove, M J Dunne, C A Ramsden, N G Morgan, S L Chan.   

Abstract

We have employed an amino derivative of the imidazoline ligand, efaroxan, to isolate imidazoline binding proteins from solubilised extracts of rat brain, by affinity chromatography. A number of proteins were specifically retained on the affinity column and one of these was immunoreactive with an antiserum raised against the ion conducting pore component of the ATP-sensitive potassium channel. Patch clamp experiments confirmed that, like its parent compound, amino-efaroxan blocks ATP-sensitive potassium channels in human pancreatic beta-cells and can stimulate the insulin secretion from these cells. The results reveal that a member of the ion conducting pore component family is strongly associated with imidazoline binding proteins in brain and in the endocrine pancreas.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10218583     DOI: 10.1016/s0014-5793(99)00264-1

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  5 in total

1.  Multiple effector pathways regulate the insulin secretory response to the imidazoline RX871024 in isolated rat pancreatic islets.

Authors:  M Mourtada; S L Chan; S A Smith; N G Morgan
Journal:  Br J Pharmacol       Date:  1999-07       Impact factor: 8.739

2.  Essential role of the imidazoline moiety in the insulinotropic effect but not the KATP channel-blocking effect of imidazolines; a comparison of the effects of efaroxan and its imidazole analogue, KU14R.

Authors:  C Bleck; A Wienbergen; I Rustenbeck
Journal:  Diabetologia       Date:  2005-11-11       Impact factor: 10.122

3.  Mechanisms of antihyperglycaemic action of efaroxan in mice: time for reappraisal of α2A-adrenergic antagonism in the treatment of type 2 diabetes?

Authors:  Z Lehner; K Stadlbauer; I Adorjan; I Rustenbeck; M Belz; A Fenzl; V A M de Cillia; D Gruber; L Bauer; K Frobel; B Brunmair; A Luger; C Fürnsinn
Journal:  Diabetologia       Date:  2012-08-18       Impact factor: 10.122

4.  Identification of the monomeric G-protein, Rhes, as an efaroxan-regulated protein in the pancreatic beta-cell.

Authors:  Sue L F Chan; Lara K Monks; Hongwei Gao; Pamela Deaville; Noel G Morgan
Journal:  Br J Pharmacol       Date:  2002-05       Impact factor: 8.739

5.  Novel I1-Imidazoline Agonist S43126 Augment Insulin Secretion in Min6 Cells.

Authors:  Jerusalem Tesfai; Louis Crane; Genevieve Baziard-Mouysset; Lincoln P Edwards
Journal:  J Diabetes Metab       Date:  2012-04-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.